Company / Total Debt
Vera Therapeutics, Inc. Total Debt History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$74.8M
FY2025
5-year range
$4.9M / $74.8M
FY2021-FY2025
Trend
+47.6%
vs FY2024
Sector context
#65 of 83
Health Care
What the data says
Vera Therapeutics, Inc.'s total debt of $75M is lower than 78% of companies in the Health Care sector (FY2025). Total Debt has increased for 5 consecutive years, from $0 in FY2020 to $75M in FY2025.
Based on SEC 10-K filings.
$75M in FY2025 with a 3-year CAGR of +44.5%.
Increased from $50M to $75M over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- +44.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 22% in Health CareTop 22% of 83This company $74.8M Sector average $6.2B
▼
-98.8% below sector average
Key checks
Key Insights
- Vera Therapeutics, Inc.'s total debt has grown for 4 consecutive years.
- 3-year CAGR of +44.5%, indicating consistent growth.
- In FY2025, total debt increased 47.6% year-over-year.
- Ranks #65 out of 83 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $74.8M | +47.6% |
| FY2024 | $50.7M | +1.6% |
| FY2023 | $49.9M | +101.0% |
| FY2022 | $24.8M | +404.0% |
| FY2021 | $4.9M | - |
| FY2020 | $0 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026